Kawasaki Disease Diagnostic Criteria
Diagnoses Kawasaki disease using AHA/JCS classic and incomplete criteria. Guides IVIG and aspirin therapy to prevent coronary artery aneurysms.
Score interpretation
→ Consider alternative diagnosis; if incomplete Kawasaki suspected: CRP, ESR, echo; consult paediatric rheumatology; treat if 2-3 criteria + abnormal echo or elevated CRP/ESR
→ Urgent IVIG 2g/kg single infusion; aspirin 30-50mg/kg/day (high dose until afebrile, then 3-5mg/kg/day); echocardiogram; paediatric cardiology review
→ IVIG 2g/kg urgently; high-dose aspirin; echocardiogram at diagnosis, 2 weeks, 6-8 weeks; if IVIG-resistant (fever persists 36h): repeat IVIG or infliximab or corticosteroids; coronary artery aneurysm monitoring
Interpretation bands for the Kawasaki Disease. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Colchicine (Pericarditis / Post-MI Inflammation) · Pericarditis / Coronary Inflammation
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Colchicine · Anti-inflammatory — Neutrophilic Dermatoses / Vasculitis
- Acetazolamide (Ménière's Disease) · Carbonic Anhydrase Inhibitor (Diuretic)
- Zinc acetate · Zinc salt (Wilson's disease)
- Sulfasalazine · Aminosalicylate / Disease-Modifying Antirheumatic Drug (DMARD)
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.